IOVA
Iovance Biotherapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Iovance Biotherapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report5 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+43.09%
vs ±17.9% implied · ×2.40
shaded = implied · ▲▼ = realized
Expected move
Inputs8Q avg ±26.6%·×0.54·cheap
spot 8.48exp Nov 6ATM strike 8.5ATM straddle 1.43IV 152%
Iovance Biotherapeutics, Inc.
8.47
−1.09 · −11.40%
post 8.45 −0.24%
No thesis.
Linked news
News| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $153.7M | 12.52% | +18.91% | |
| 2 | MHR Fund ManagementMHR Fund | $120.5M | 9.81% | 0.00% | |
| 3 | State StreetState Streetindex-like | $101.8M | 8.29% | +40.29% | |
| 4 | Two Sigma InvestmentsTwo Sigma | $79.1M | 6.44% | +38.89% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $75.7M | 6.17% | +9.55% | |
| 6 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $59.9M | 4.87% | +22.97% | |
| 7 | Geode Capital ManagementGeodeindex-like | $43.0M | 3.50% | +20.44% | |
| 8 | Millennium ManagementMillennium | $35.5M | 2.89% | −9.44% | |
| 9 | Susquehanna International GroupSusquehanna International | $32.1M | 2.61% | +15.21% | |
| 10 | Dimensional Fund AdvisorsDimensional | $26.9M | 2.19% | +144.19% | |
| 11 | Jane Street GroupJane Street | $22.8M | 1.85% | +16.86% | |
| 12 | Palo Alto InvestorsPalo Alto Investors | $22.0M | 1.79% | −16.59% | |
| 13 | Goldman Sachs GroupGoldman Sachs | $21.2M | 1.73% | −41.82% | |
| 14 | NuveenNuveenindex-like | $20.8M | 1.69% | +36.37% | |
| 15 | Bank of AmericaBank of America | $20.8M | 1.69% | −41.18% | |
| 16 | Morgan StanleyMorgan Stanley | $20.7M | 1.69% | −19.59% | |
| 17 | Jupiter Asset ManagementJupiter | $18.9M | 1.54% | new | |
| 18 | Northern TrustNorthern Trustindex-like | $17.3M | 1.41% | +44.47% | |
| 19 | AQR Capital ManagementAQR | $16.1M | 1.31% | +519.96% | |
| 20 | Citadel AdvisorsCitadel | $15.1M | 1.23% | −5.78% | |
| 21 | Wells FargoWells Fargo | $13.5M | 1.10% | +56.72% | |
| 22 | Charles Schwab Investment ManagementCharles Schwabindex-like | $13.4M | 1.09% | +15.66% | |
| 23 | HRT FinancialHRT Financial | $12.9M | 1.05% | −11.14% | |
| 24 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $10.6M | 0.86% | +16.42% | |
| 25 | JPMorgan ChaseJPMorgan Chase | $10.2M | 0.83% | −2.76% |
292 managers report $1.2B of Iovance Biotherapeutics on form 13F for the quarter ended Jun 30 '26. 25 of them hold 80% of it; BlackRock is largest at 12.52%.